Medtronic Inc News
-
Nanostim Inc.’s miniaturized pacemaker, a device the size of a AAA battery placed entirely in the heart, appeared promising in its first human trials.
-
Gianna Chien is somewhat different from all the other researchers reporting on their work today to more than 8,000 doctors at the Heart Rhythm Society meeting.
-
St. Jude Medical Inc.’s Durata lead, the wire used to connect life-saving defibrillators to the heart, proved safe and reliable in an independent review that should ease concerns about its use, researchers said.
-
Medtronic Inc. won U.S. regulatory approval for its Viva device used to resynchronize the beating of the heart and reduce hospitalizations for heart failure.
-
A Medtronic Inc. device used to stimulate the brain to treat Parkinson’s disease and other neurological conditions has a potentially life-threatening flaw that triggered the highest-level warning from U.S. regulators.
-
Edwards Lifesciences Corp., the biggest-maker of aortic heart valves implanted with a catheter, plunged the most in a dozen years after the company cut its 2013 forecast on slower-than-anticipated sales.
-
Nike Inc., the world’s largest sporting-goods company, boosted the industry’s biggest cash hoard by entering the bond market for the first time in a decade with a new $1 billion offering.
-
Wal-Mart Stores Inc. is winning the lowest borrowing costs this year as its AA credit rating offsets challenges from a corruption probe to reports of thinly stocked shelves.
-
Medtronic Inc., the world’s biggest maker of heart-rhythm devices, sold $3 billion of bonds in a three-part offering, its first sale in a year.
-
Medtronic Inc. must try again to prove that it didn’t infringe two patents controlled by Boston Scientific Corp. over implantable defibrillators, a U.S. appeals court said today.
|
|
Most Popular on Bloomberg
|
| |
Rate this Page